Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | TAS3351 |
Trade Name | |
Synonyms | TAS-3351|TAS 3351 |
Drug Descriptions |
TAS3351 is a 4th-generation EGFR inhibitor with activity against EGFR C797S and T790M, potentially reducing cell viability and tumor growth (Cancer Res 2022;82(12_Suppl):Abstract nr 3259). |
DrugClasses | EGFR Inhibitor 4th gen 16 |
CAS Registry Number | NA |
NCIT ID | NA |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
TAS3351 | TAS3351 | 0 | 1 |